Buchumschlag

Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Vaisak O. Nair, Zachary A. Yetmar, Bismarck S. Bisono‐Garcia, Lisa Brumble, Holenarasipur R. Vikram, Raymund R. Razonable, Elena Beam
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Clinical Transplantation
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
von: Abdallah Mughrabi, et al.
Veröffentlicht: (2026)

Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients
von: Chia‐Yu Chiu, et al.
Veröffentlicht: (2024)

Posttransplant HBV Vaccine Compliance, Seroprotection, and Kinetics of Hepatitis B Surface Antibody in Thoracic Organ Transplant Recipients
von: Chia‐Yu Chiu, et al.
Veröffentlicht: (2025)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
von: Lemuel R. Non, et al.
Veröffentlicht: (2024)

Discordance in serology for cytomegalovirus, Epstein‐Barr virus and toxoplasma among thoracic organ donors
von: Chia‐Yu Chiu, et al.
Veröffentlicht: (2024)

Surgical Site Infection After Intestine Transplantation: Risk Factors and Outcomes
von: Mayyadah H. Alabdely, et al.
Veröffentlicht: (2025)

Disseminated Mycobacterium bovis ‐BCG Infection Following Intravesical BCG Administration in Solid Organ Transplant Recipients
von: Paavana Varanasi, et al.
Veröffentlicht: (2026)

Risk Factors and Outcomes of Invasive Candida Infections in Heart Transplant Recipients: A Case‐Control Study
von: Majd Alsoubani, et al.
Veröffentlicht: (2025)

Impact of Early Rejection Treatment on Infection Development in Kidney Transplant Recipients: A Propensity Analysis
von: Simran Gupta, et al.
Veröffentlicht: (2024)

Confronting the Challenges of Prevention, Diagnosis, and Management of Donor‐Derived Coccidioidomycosis
von: Holenarasipur R. Vikram
Veröffentlicht: (2024)

Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients
von: John‐Anthony Coppola, et al.
Veröffentlicht: (2025)

De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
von: Hanna L. Kleiboeker, et al.
Veröffentlicht: (2025)

Clinical Characteristics and Outcomes of Pneumocystis Pneumonia in Solid Organ Transplant Recipients
von: Aaron M. Pulsipher, et al.
Veröffentlicht: (2026)

Outcomes of Heart Transplantation Based on Recipient’s Clinical Profile: 21-Year Experience
von: Margarita A. Peradejordi Lastras
Veröffentlicht: (2016)

Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
von: Natasha Banga, et al.
Veröffentlicht: (2025)

Risk Factors and Outcomes of Reintubation Following Combined Heart‐Lung Transplantation
von: Ye In Christopher Kwon, et al.
Veröffentlicht: (2026)

Evolving Trends and Impact of Waitlist Transfusion on Recipient Outcomes Following Heart Transplantation
von: Yeahwa Hong, et al.
Veröffentlicht: (2024)

A Qualitative Study of Cytomegalovirus Awareness and Experience in Kidney Transplant Recipients
von: Afolarin A. Otunla, et al.
Veröffentlicht: (2026)

Expanding Perspectives on Sarcopenia and Frailty Risk in Heart Transplant Recipients
von: Lien‐Chung Wei, et al.
Veröffentlicht: (2025)

Lung Transplant Outcomes Following Treatment of Pre‐Transplant MAC Pulmonary Infection
von: Prasanth Balasubramanian, et al.
Veröffentlicht: (2025)

Contemporary Cytomegalovirus (CMV) Infections in Low‐Risk CMV Seronegative Recipients of Solid Organ Transplants From CMV Seronegative Donors (D−/R−): Time to Reexamine Donor CMV Serostatus
von: Madeleine R. Heldman, et al.
Veröffentlicht: (2024)

Incidence and Risk Factors of Obesity and Overweight in Kidney Transplant Recipients and Their Effect on Graft Outcome
von: Muhammad Abdul Mabood Khalil, et al.
Veröffentlicht: (2025)

Induction Regimens and Kidney Re‐Transplant Outcomes after BK Nephropathy–Related Graft Loss: A U.S. Cohort Study
von: Rasha El‐Rifai, et al.
Veröffentlicht: (2026)

Efficacy of a Single Dose of Intravesical Aminoglycoside for the Prevention of Urinary Tract Infections in Kidney Transplant Recipients
von: Sarah Dean, et al.
Veröffentlicht: (2026)

Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
von: Maria Alejandra Mendoza, et al.
Veröffentlicht: (2024)

Suitability of Infant Heart Transplant Recipients to Serve as Domino Partial Heart Transplant Donors
von: Meagan O. Rogers, et al.
Veröffentlicht: (2024)

A DOOR to Defining New Outcomes for Research in Transplant Recipients’ Infections
von: Francesco Cogliati Dezza, et al.
Veröffentlicht: (2026)

Outcomes of Donor‐Recipient Size Mismatch in Donation After Circulatory Death Heart Transplantation
von: Iris Feng, et al.
Veröffentlicht: (2025)

The Clinical Impact of Antibiotic Allergy Labels on One‐Year Outcomes of Solid Organ Transplant Recipients
von: Sashi Niranjan Nair, et al.
Veröffentlicht: (2026)

Twelve‐Month Clinical and Cost Outcomes of Removal of Cytomegalovirus Intravenous Immune Globulin From Heart Transplantation Protocol
von: Madhumita Rao, et al.
Veröffentlicht: (2025)

Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
von: Marilyne Daher, et al.
Veröffentlicht: (2025)

Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient
von: Ana Khazan, et al.
Veröffentlicht: (2026)

Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept
von: Madeleine R. Heldman, et al.
Veröffentlicht: (2024)

Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era
von: Lana Hasan, et al.
Veröffentlicht: (2025)

Premature Discontinuation of Trimethoprim/Sulfamethoxazole Prophylaxis in Abdominal Transplant Recipients: A Deeper Dive
von: Madeline R. Hudson, et al.
Veröffentlicht: (2025)

Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
von: Eishan Ashwat, et al.
Veröffentlicht: (2025)

Outcomes and Tolerability of Early Mammalian Target of Rapamycin Inhibitor Initiation for Renal Sparing in Heart Transplant Recipients
von: Avery Marcotte, et al.
Veröffentlicht: (2025)

Characteristics and Clinical Outcomes of Postoperative Pleural Space Infections Among Lung Transplant Recipients
von: Miranda Arzate, et al.
Veröffentlicht: (2026)

Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis
von: David Moynan, et al.
Veröffentlicht: (2024)

Low Absolute Lymphocyte Count Associated With Anti‐Thymocyte Globulin Induction May Be a Predictor of Early Cytomegalovirus Infection in Pediatric Heart Transplantation
von: Allyson Chan, et al.
Veröffentlicht: (2025)